Novel motif:49: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif49_ACAGRG
|novel_motifs_human_sample_pval=11376-118A8_11051;0.993838,11327-117E4_11969;0.7282,11473-119C6_11054;0.397707,11474-119C7_12067;0.404773,...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:46, 9 September 2013
name: | motif49_ACAGRG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0050896 | response to stimulus | 2.662629e-43 |
GO:0007154 | cell communication | 2.255728e-41 |
GO:0023052 | signaling | 2.313434e-41 |
GO:0048583 | regulation of response to stimulus | 4.633373e-41 |
GO:0007165 | signal transduction | 1.137537e-40 |
GO:0006955 | immune response | 4.535971e-39 |
GO:0051716 | cellular response to stimulus | 1.203345e-37 |
GO:0006952 | defense response | 1.432362e-37 |
GO:0002376 | immune system process | 1.808973e-34 |
GO:0007166 | cell surface receptor linked signaling pathway | 1.639951e-30 |
GO:0065007 | biological regulation | 5.006086e-29 |
GO:0048584 | positive regulation of response to stimulus | 4.095686e-27 |
GO:0002684 | positive regulation of immune system process | 5.148641e-27 |
GO:0002682 | regulation of immune system process | 7.826931e-27 |
GO:0050789 | regulation of biological process | 3.670727e-26 |
GO:0006954 | inflammatory response | 3.382461e-25 |
GO:0006909 | phagocytosis | 3.298994e-22 |
GO:0048518 | positive regulation of biological process | 5.329200e-22 |
GO:0023051 | regulation of signaling | 2.028599e-21 |
GO:0042221 | response to chemical stimulus | 2.191983e-21 |
GO:0009966 | regulation of signal transduction | 2.763244e-21 |
GO:0032501 | multicellular organismal process | 3.801703e-21 |
GO:0006950 | response to stress | 2.996636e-19 |
GO:0035556 | intracellular signal transduction | 4.372925e-19 |
GO:0032101 | regulation of response to external stimulus | 8.656977e-19 |
GO:0065008 | regulation of biological quality | 1.251789e-18 |
GO:0050776 | regulation of immune response | 1.424161e-18 |
GO:0070613 | regulation of protein processing | 2.095519e-18 |
GO:0050794 | regulation of cellular process | 6.613466e-18 |
GO:0007155 | cell adhesion | 1.948671e-17 |
GO:0009628 | response to abiotic stimulus | 3.100842e-17 |
GO:0009605 | response to external stimulus | 7.622679e-17 |
GO:0010466 | negative regulation of peptidase activity | 2.368275e-16 |
GO:0050778 | positive regulation of immune response | 3.934298e-16 |
GO:0010951 | negative regulation of endopeptidase activity | 6.407896e-16 |
GO:0043067 | regulation of programmed cell death | 1.491756e-15 |
GO:0001817 | regulation of cytokine production | 2.946184e-15 |
GO:0051346 | negative regulation of hydrolase activity | 3.754706e-15 |
GO:0010941 | regulation of cell death | 4.261596e-15 |
GO:0042981 | regulation of apoptosis | 4.970008e-15 |
GO:0048522 | positive regulation of cellular process | 1.170524e-14 |
GO:0032103 | positive regulation of response to external stimulus | 1.399675e-14 |
GO:0010955 | negative regulation of protein processing | 1.970096e-14 |
GO:0002696 | positive regulation of leukocyte activation | 4.873963e-14 |
GO:0001819 | positive regulation of cytokine production | 5.013294e-14 |
GO:0009611 | response to wounding | 5.060214e-14 |
GO:0045087 | innate immune response | 7.356274e-14 |
GO:0003008 | system process | 8.113644e-14 |
GO:0010646 | regulation of cell communication | 1.025065e-13 |
GO:0002253 | activation of immune response | 1.026676e-13 |
GO:0061024 | membrane organization | 1.758147e-13 |
GO:0050867 | positive regulation of cell activation | 1.847178e-13 |
GO:0016044 | cellular membrane organization | 1.991379e-13 |
GO:0007586 | digestion | 2.100270e-13 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 2.330916e-13 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.412716e-13 |
GO:0010740 | positive regulation of intracellular protein kinase cascade | 3.585449e-13 |
GO:0051896 | regulation of protein kinase B signaling cascade | 4.123303e-13 |
GO:0009987 | cellular process | 4.214668e-13 |
GO:0002697 | regulation of immune effector process | 5.033348e-13 |
GO:0002577 | regulation of antigen processing and presentation | 5.038727e-13 |
GO:0051336 | regulation of hydrolase activity | 5.055207e-13 |
GO:0030449 | regulation of complement activation | 5.203989e-13 |
GO:0016064 | immunoglobulin mediated immune response | 5.340259e-13 |
GO:0031347 | regulation of defense response | 6.001832e-13 |
GO:0002407 | dendritic cell chemotaxis | 7.462457e-13 |
GO:0072376 | protein activation cascade | 8.298594e-13 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 8.407073e-13 |
GO:0034754 | cellular hormone metabolic process | 1.045209e-12 |
GO:0050920 | regulation of chemotaxis | 1.453443e-12 |
GO:0050795 | regulation of behavior | 1.823680e-12 |
GO:0016192 | vesicle-mediated transport | 2.193722e-12 |
GO:0080134 | regulation of response to stress | 2.385770e-12 |
GO:0051234 | establishment of localization | 3.028698e-12 |
GO:0010288 | response to lead ion | 3.076140e-12 |
GO:0019221 | cytokine-mediated signaling pathway | 3.462865e-12 |
GO:0032879 | regulation of localization | 3.631918e-12 |
GO:0048520 | positive regulation of behavior | 4.217991e-12 |
GO:0051179 | localization | 4.697349e-12 |
GO:0050727 | regulation of inflammatory response | 5.765037e-12 |
GO:0006953 | acute-phase response | 6.795879e-12 |
GO:0006956 | complement activation | 7.029872e-12 |
GO:0030335 | positive regulation of cell migration | 8.369835e-12 |
GO:0010033 | response to organic substance | 8.547848e-12 |
GO:0002250 | adaptive immune response | 8.642303e-12 |
GO:2000147 | positive regulation of cell motility | 8.879649e-12 |
GO:0019724 | B cell mediated immunity | 9.050831e-12 |
GO:0042445 | hormone metabolic process | 1.098122e-11 |
GO:0006897 | endocytosis | 1.455855e-11 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 1.816538e-11 |
GO:0002687 | positive regulation of leukocyte migration | 2.166431e-11 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 3.503099e-11 |
GO:0006810 | transport | 3.916732e-11 |
GO:0030198 | extracellular matrix organization | 3.920989e-11 |
GO:0000093 | mitotic telophase | 3.926441e-11 |
GO:0046626 | regulation of insulin receptor signaling pathway | 4.096876e-11 |
GO:0032908 | regulation of transforming growth factor beta1 production | 4.637483e-11 |
GO:0000302 | response to reactive oxygen species | 4.807728e-11 |
GO:0045321 | leukocyte activation | 5.666786e-11 |
GO:0050921 | positive regulation of chemotaxis | 6.623734e-11 |
GO:0002920 | regulation of humoral immune response | 6.701273e-11 |
GO:0006775 | fat-soluble vitamin metabolic process | 7.133440e-11 |
GO:0043206 | fibril organization | 9.759097e-11 |
GO:0002449 | lymphocyte mediated immunity | 1.171223e-10 |
GO:0002252 | immune effector process | 1.268274e-10 |
GO:0050870 | positive regulation of T cell activation | 1.289057e-10 |
GO:0006959 | humoral immune response | 1.305235e-10 |
GO:0044281 | small molecule metabolic process | 1.377214e-10 |
GO:0051272 | positive regulation of cellular component movement | 1.671124e-10 |
GO:0031295 | T cell costimulation | 1.766607e-10 |
GO:0009607 | response to biotic stimulus | 2.246957e-10 |
GO:0040017 | positive regulation of locomotion | 2.259519e-10 |
GO:0007600 | sensory perception | 2.343225e-10 |
GO:0009266 | response to temperature stimulus | 2.522262e-10 |
GO:0051251 | positive regulation of lymphocyte activation | 2.716920e-10 |
GO:0002443 | leukocyte mediated immunity | 2.882733e-10 |
GO:0006935 | chemotaxis | 3.035946e-10 |
GO:0030334 | regulation of cell migration | 3.168612e-10 |
GO:0030595 | leukocyte chemotaxis | 3.293251e-10 |
GO:0042592 | homeostatic process | 3.404881e-10 |
GO:0044258 | intestinal lipid catabolic process | 3.923704e-10 |
GO:0018350 | protein esterification | 3.923704e-10 |
GO:0009749 | response to glucose stimulus | 4.645109e-10 |
GO:0050877 | neurological system process | 5.840463e-10 |
GO:0031667 | response to nutrient levels | 5.931567e-10 |
GO:2000145 | regulation of cell motility | 6.379312e-10 |
GO:0045834 | positive regulation of lipid metabolic process | 8.533962e-10 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 8.598613e-10 |
GO:0071636 | positive regulation of transforming growth factor beta production | 9.438701e-10 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 9.880513e-10 |
GO:0050790 | regulation of catalytic activity | 1.079107e-9 |
GO:0010817 | regulation of hormone levels | 1.160536e-9 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 1.194595e-9 |
GO:0006917 | induction of apoptosis | 1.225991e-9 |
GO:0071622 | regulation of granulocyte chemotaxis | 1.229261e-9 |
GO:0002688 | regulation of leukocyte chemotaxis | 1.252898e-9 |
GO:0010627 | regulation of intracellular protein kinase cascade | 1.261972e-9 |
GO:0051049 | regulation of transport | 1.405015e-9 |
GO:0003334 | keratinocyte development | 1.425836e-9 |
GO:0048545 | response to steroid hormone stimulus | 1.430835e-9 |
GO:0043086 | negative regulation of catalytic activity | 1.463341e-9 |
GO:0002685 | regulation of leukocyte migration | 1.624668e-9 |
GO:0034097 | response to cytokine stimulus | 1.797293e-9 |
GO:0008228 | opsonization | 1.799320e-9 |
GO:0051270 | regulation of cellular component movement | 1.872094e-9 |
GO:0006958 | complement activation, classical pathway | 1.901454e-9 |
GO:0052547 | regulation of peptidase activity | 1.983015e-9 |
GO:0046314 | phosphocreatine biosynthetic process | 2.044602e-9 |
GO:0002526 | acute inflammatory response | 2.158028e-9 |
GO:0007243 | intracellular protein kinase cascade | 2.193298e-9 |
GO:0008202 | steroid metabolic process | 2.334563e-9 |
GO:0002579 | positive regulation of antigen processing and presentation | 2.482332e-9 |
GO:0012502 | induction of programmed cell death | 2.521046e-9 |
GO:0045916 | negative regulation of complement activation | 2.540888e-9 |
GO:0051707 | response to other organism | 2.562073e-9 |
GO:0009967 | positive regulation of signal transduction | 2.609757e-9 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 2.665939e-9 |
GO:0009408 | response to heat | 2.913020e-9 |
GO:0043085 | positive regulation of catalytic activity | 3.273912e-9 |
GO:0043405 | regulation of MAP kinase activity | 3.307683e-9 |
GO:0007264 | small GTPase mediated signal transduction | 3.337601e-9 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 3.341233e-9 |
GO:0010759 | positive regulation of macrophage chemotaxis | 3.537352e-9 |
GO:0040012 | regulation of locomotion | 3.751581e-9 |
GO:0043900 | regulation of multi-organism process | 3.908968e-9 |
GO:0002764 | immune response-regulating signaling pathway | 4.047644e-9 |
GO:0043277 | apoptotic cell clearance | 4.166856e-9 |
GO:0070887 | cellular response to chemical stimulus | 4.365455e-9 |
GO:0016525 | negative regulation of angiogenesis | 4.755084e-9 |
GO:0002694 | regulation of leukocyte activation | 4.884613e-9 |
GO:0071702 | organic substance transport | 5.043639e-9 |
GO:0071634 | regulation of transforming growth factor beta production | 5.190808e-9 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 5.350021e-9 |
GO:0050729 | positive regulation of inflammatory response | 5.454441e-9 |
GO:0042137 | sequestering of neurotransmitter | 6.110616e-9 |
GO:0060696 | regulation of phospholipid catabolic process | 6.151291e-9 |
GO:0006968 | cellular defense response | 6.480506e-9 |
GO:0033189 | response to vitamin A | 6.998545e-9 |
GO:0051480 | cytosolic calcium ion homeostasis | 7.129520e-9 |
GO:0007267 | cell-cell signaling | 7.318684e-9 |
GO:0042363 | fat-soluble vitamin catabolic process | 7.393902e-9 |
GO:0051239 | regulation of multicellular organismal process | 7.767068e-9 |
GO:0009617 | response to bacterium | 7.821952e-9 |
GO:0050865 | regulation of cell activation | 8.230419e-9 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 9.876844e-9 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 1.012546e-8 |
GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development | 1.348522e-8 |
GO:0006629 | lipid metabolic process | 1.432202e-8 |
GO:0010758 | regulation of macrophage chemotaxis | 1.435735e-8 |
GO:0048585 | negative regulation of response to stimulus | 1.481847e-8 |
GO:0051051 | negative regulation of transport | 1.499125e-8 |
GO:0000165 | MAPKKK cascade | 1.581930e-8 |
GO:0043406 | positive regulation of MAP kinase activity | 1.744686e-8 |
GO:0021984 | adenohypophysis development | 1.843660e-8 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.976968e-8 |
GO:0015872 | dopamine transport | 2.151563e-8 |
GO:0030155 | regulation of cell adhesion | 2.357828e-8 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 2.435076e-8 |
GO:0032456 | endocytic recycling | 2.437485e-8 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 2.440514e-8 |
GO:0051591 | response to cAMP | 2.578382e-8 |
GO:0007522 | visceral muscle development | 2.858260e-8 |
GO:0000090 | mitotic anaphase | 3.005079e-8 |
GO:0051657 | maintenance of organelle location | 3.414288e-8 |
GO:0051704 | multi-organism process | 3.481408e-8 |
GO:0033273 | response to vitamin | 3.612947e-8 |
GO:0060326 | cell chemotaxis | 3.664916e-8 |
GO:0032368 | regulation of lipid transport | 3.788049e-8 |
GO:0006776 | vitamin A metabolic process | 3.966484e-8 |
GO:0019882 | antigen processing and presentation | 4.194731e-8 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 4.229884e-8 |
GO:0031349 | positive regulation of defense response | 4.273058e-8 |
GO:0045112 | integrin biosynthetic process | 4.333959e-8 |
GO:0023056 | positive regulation of signaling | 4.404613e-8 |
GO:0043068 | positive regulation of programmed cell death | 4.429085e-8 |
GO:0010812 | negative regulation of cell-substrate adhesion | 4.605864e-8 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 4.619901e-8 |
GO:0042742 | defense response to bacterium | 4.815001e-8 |
GO:0032536 | regulation of cell projection size | 4.865207e-8 |
GO:0044240 | multicellular organismal lipid catabolic process | 5.260233e-8 |
GO:0008219 | cell death | 5.599776e-8 |
GO:0010757 | negative regulation of plasminogen activation | 5.826039e-8 |
GO:0002757 | immune response-activating signal transduction | 5.898467e-8 |
GO:0002544 | chronic inflammatory response | 6.096515e-8 |
GO:0015849 | organic acid transport | 6.229272e-8 |
GO:0042104 | positive regulation of activated T cell proliferation | 6.377400e-8 |
GO:0010755 | regulation of plasminogen activation | 6.540082e-8 |
GO:0009746 | response to hexose stimulus | 6.703632e-8 |
GO:0044236 | multicellular organismal metabolic process | 6.753439e-8 |
GO:0006820 | anion transport | 6.816041e-8 |
GO:0032502 | developmental process | 6.958514e-8 |
GO:0010647 | positive regulation of cell communication | 7.266258e-8 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 7.825251e-8 |
GO:0016265 | death | 8.189529e-8 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 8.797780e-8 |
GO:0045730 | respiratory burst | 8.875120e-8 |
GO:0052548 | regulation of endopeptidase activity | 9.166014e-8 |
GO:0001503 | ossification | 9.323522e-8 |
GO:0046942 | carboxylic acid transport | 9.370548e-8 |
GO:0050764 | regulation of phagocytosis | 9.839418e-8 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 9.889370e-8 |
GO:0061025 | membrane fusion | 1.046112e-7 |
GO:0050863 | regulation of T cell activation | 1.077906e-7 |
GO:0033674 | positive regulation of kinase activity | 1.085229e-7 |
GO:0006944 | cellular membrane fusion | 1.091377e-7 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.096679e-7 |
GO:0035411 | catenin import into nucleus | 1.100971e-7 |
GO:0002821 | positive regulation of adaptive immune response | 1.132814e-7 |
GO:0043410 | positive regulation of MAPKKK cascade | 1.161912e-7 |
GO:0002922 | positive regulation of humoral immune response | 1.172766e-7 |
GO:0009991 | response to extracellular stimulus | 1.199156e-7 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.199565e-7 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 1.219335e-7 |
GO:0065009 | regulation of molecular function | 1.319294e-7 |
GO:0010942 | positive regulation of cell death | 1.367116e-7 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 1.420314e-7 |
GO:0071345 | cellular response to cytokine stimulus | 1.457338e-7 |
GO:0051240 | positive regulation of multicellular organismal process | 1.536556e-7 |
GO:0043065 | positive regulation of apoptosis | 1.545834e-7 |
GO:0014012 | peripheral nervous system axon regeneration | 1.565243e-7 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.599525e-7 |
GO:0034284 | response to monosaccharide stimulus | 1.601024e-7 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.688709e-7 |
GO:0044093 | positive regulation of molecular function | 1.707065e-7 |
GO:0050829 | defense response to Gram-negative bacterium | 1.732389e-7 |
GO:0048878 | chemical homeostasis | 1.738716e-7 |
GO:0010763 | positive regulation of fibroblast migration | 1.754288e-7 |
GO:0071675 | regulation of mononuclear cell migration | 1.762402e-7 |
GO:0009071 | serine family amino acid catabolic process | 1.811338e-7 |
GO:0010631 | epithelial cell migration | 1.816352e-7 |
GO:0046724 | oxalic acid secretion | 1.905134e-7 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 1.905134e-7 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 2.001382e-7 |
GO:0051347 | positive regulation of transferase activity | 2.019055e-7 |
GO:0008624 | induction of apoptosis by extracellular signals | 2.039008e-7 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 2.404449e-7 |
GO:0043030 | regulation of macrophage activation | 2.454578e-7 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 2.464667e-7 |
GO:0006915 | apoptosis | 2.586908e-7 |
GO:0005979 | regulation of glycogen biosynthetic process | 2.667813e-7 |
GO:0071732 | cellular response to nitric oxide | 2.687527e-7 |
GO:0044130 | negative regulation of growth of symbiont in host | 2.764253e-7 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 2.822977e-7 |
GO:0034763 | negative regulation of transmembrane transport | 2.931220e-7 |
GO:0000187 | activation of MAPK activity | 2.949649e-7 |
GO:0009612 | response to mechanical stimulus | 2.951681e-7 |
GO:0040011 | locomotion | 3.026593e-7 |
GO:0015721 | bile acid and bile salt transport | 3.052631e-7 |
GO:0045766 | positive regulation of angiogenesis | 3.061120e-7 |
GO:0006720 | isoprenoid metabolic process | 3.142136e-7 |
GO:0044341 | sodium-dependent phosphate transport | 3.483256e-7 |
GO:0070208 | protein heterotrimerization | 3.631755e-7 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 3.766380e-7 |
GO:0001775 | cell activation | 4.165970e-7 |
GO:0006721 | terpenoid metabolic process | 4.436866e-7 |
GO:0002883 | regulation of hypersensitivity | 4.509744e-7 |
GO:0050671 | positive regulation of lymphocyte proliferation | 4.583826e-7 |
GO:0032680 | regulation of tumor necrosis factor production | 4.785730e-7 |
GO:0007009 | plasma membrane organization | 4.811748e-7 |
GO:0009303 | rRNA transcription | 4.918293e-7 |
GO:0051937 | catecholamine transport | 5.058337e-7 |
GO:0071705 | nitrogen compound transport | 5.115689e-7 |
GO:0012501 | programmed cell death | 5.175916e-7 |
GO:0007584 | response to nutrient | 5.404254e-7 |
GO:0032370 | positive regulation of lipid transport | 5.453088e-7 |
GO:0001869 | negative regulation of complement activation, lectin pathway | 5.643841e-7 |
GO:0034762 | regulation of transmembrane transport | 6.059147e-7 |
GO:0044092 | negative regulation of molecular function | 6.327923e-7 |
GO:0051322 | anaphase | 6.376032e-7 |
GO:0006875 | cellular metal ion homeostasis | 6.407626e-7 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 6.601201e-7 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 6.781648e-7 |
GO:0002673 | regulation of acute inflammatory response | 6.959888e-7 |
GO:0002699 | positive regulation of immune effector process | 6.995953e-7 |
GO:0045765 | regulation of angiogenesis | 7.099095e-7 |
GO:0002237 | response to molecule of bacterial origin | 7.120029e-7 |
GO:0090130 | tissue migration | 7.391799e-7 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 7.444224e-7 |
GO:0055065 | metal ion homeostasis | 7.489950e-7 |
GO:0042990 | regulation of transcription factor import into nucleus | 7.588041e-7 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 7.639601e-7 |
GO:0030100 | regulation of endocytosis | 7.909319e-7 |
GO:2000097 | regulation of smooth muscle cell-matrix adhesion | 8.109547e-7 |
GO:0003051 | angiotensin-mediated drinking behavior | 8.500477e-7 |
GO:0050690 | regulation of defense response to virus by virus | 8.516622e-7 |
GO:0016043 | cellular component organization | 8.674808e-7 |
GO:0032787 | monocarboxylic acid metabolic process | 8.934138e-7 |
GO:0010872 | regulation of cholesterol esterification | 9.051300e-7 |
GO:0006811 | ion transport | 9.410215e-7 |
GO:0042866 | pyruvate biosynthetic process | 9.637766e-7 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 9.753446e-7 |
GO:0006707 | cholesterol catabolic process | 9.947721e-7 |
GO:0006911 | phagocytosis, engulfment | 1.020873e-6 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 1.046683e-6 |
GO:0045860 | positive regulation of protein kinase activity | 1.071193e-6 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.103155e-6 |
GO:0006766 | vitamin metabolic process | 1.120265e-6 |
GO:0002274 | myeloid leukocyte activation | 1.133223e-6 |
GO:0032526 | response to retinoic acid | 1.171011e-6 |
GO:0030277 | maintenance of gastrointestinal epithelium | 1.201207e-6 |
GO:2000191 | regulation of fatty acid transport | 1.231398e-6 |
GO:0042396 | phosphagen biosynthetic process | 1.322504e-6 |
GO:0042493 | response to drug | 1.356121e-6 |
GO:0060263 | regulation of respiratory burst | 1.358223e-6 |
GO:0070873 | regulation of glycogen metabolic process | 1.362380e-6 |
GO:0060346 | bone trabecula formation | 1.372568e-6 |
GO:0015844 | monoamine transport | 1.406564e-6 |
GO:0071310 | cellular response to organic substance | 1.421756e-6 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 1.508348e-6 |
GO:0007292 | female gamete generation | 1.603796e-6 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 1.606887e-6 |
GO:0002679 | respiratory burst involved in defense response | 1.609131e-6 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 1.627163e-6 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 1.630107e-6 |
GO:0051482 | elevation of cytosolic calcium ion concentration involved in G-protein signaling coupled to IP3 second messenger | 1.662422e-6 |
GO:0003009 | skeletal muscle contraction | 1.743280e-6 |
GO:0051246 | regulation of protein metabolic process | 1.782520e-6 |
GO:0060548 | negative regulation of cell death | 1.837748e-6 |
GO:0071840 | cellular component organization or biogenesis | 1.861580e-6 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.913511e-6 |
GO:0034014 | response to triglyceride | 1.947415e-6 |
GO:0070665 | positive regulation of leukocyte proliferation | 1.976846e-6 |
GO:0007601 | visual perception | 1.986315e-6 |
GO:0048519 | negative regulation of biological process | 2.017704e-6 |
GO:0031064 | negative regulation of histone deacetylation | 2.019141e-6 |
GO:0043588 | skin development | 2.054862e-6 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 2.069969e-6 |
GO:0050953 | sensory perception of light stimulus | 2.116564e-6 |
GO:0031133 | regulation of axon diameter | 2.147441e-6 |
GO:0031640 | killing of cells of other organism | 2.219993e-6 |
GO:0006140 | regulation of nucleotide metabolic process | 2.247920e-6 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 2.266293e-6 |
GO:0001953 | negative regulation of cell-matrix adhesion | 2.304058e-6 |
GO:0046006 | regulation of activated T cell proliferation | 2.312784e-6 |
GO:0070417 | cellular response to cold | 2.462038e-6 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 2.561413e-6 |
GO:0045940 | positive regulation of steroid metabolic process | 2.640649e-6 |
GO:0051895 | negative regulation of focal adhesion assembly | 2.656535e-6 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 2.700585e-6 |
GO:0015809 | arginine transport | 2.816673e-6 |
GO:0090218 | positive regulation of lipid kinase activity | 2.842108e-6 |
GO:0008065 | establishment of blood-nerve barrier | 2.874411e-6 |
GO:0032496 | response to lipopolysaccharide | 2.891833e-6 |
GO:0032355 | response to estradiol stimulus | 2.953769e-6 |
GO:0010954 | positive regulation of protein processing | 2.973020e-6 |
GO:0046687 | response to chromate | 3.129875e-6 |
GO:0033986 | response to methanol | 3.129875e-6 |
GO:0007162 | negative regulation of cell adhesion | 3.181505e-6 |
GO:0034505 | tooth mineralization | 3.206368e-6 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 3.293177e-6 |
GO:0043066 | negative regulation of apoptosis | 3.335605e-6 |
GO:0042730 | fibrinolysis | 3.492859e-6 |
GO:0001516 | prostaglandin biosynthetic process | 3.596744e-6 |
GO:0002703 | regulation of leukocyte mediated immunity | 3.657894e-6 |
GO:0031099 | regeneration | 3.763747e-6 |
GO:0009629 | response to gravity | 3.807951e-6 |
GO:0019532 | oxalate transport | 3.872397e-6 |
GO:0070482 | response to oxygen levels | 4.148525e-6 |
GO:0006690 | icosanoid metabolic process | 4.212579e-6 |
GO:0043069 | negative regulation of programmed cell death | 4.224624e-6 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 4.234729e-6 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 4.262299e-6 |
GO:0007275 | multicellular organismal development | 4.451443e-6 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 4.521434e-6 |
GO:0006342 | chromatin silencing | 4.687867e-6 |
GO:0001523 | retinoid metabolic process | 4.814650e-6 |
GO:0042180 | cellular ketone metabolic process | 4.929393e-6 |
GO:0008207 | C21-steroid hormone metabolic process | 4.930655e-6 |
GO:0070875 | positive regulation of glycogen metabolic process | 4.966008e-6 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 5.187550e-6 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 5.207343e-6 |
GO:0050688 | regulation of defense response to virus | 5.284285e-6 |
GO:0006544 | glycine metabolic process | 5.288338e-6 |
GO:0043535 | regulation of blood vessel endothelial cell migration | 5.910776e-6 |
GO:0016458 | gene silencing | 6.047348e-6 |
GO:0006874 | cellular calcium ion homeostasis | 6.092462e-6 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 6.166409e-6 |
GO:0043652 | engulfment of apoptotic cell | 6.166409e-6 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 6.166409e-6 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 6.166409e-6 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 6.166409e-6 |
GO:0031960 | response to corticosteroid stimulus | 6.317746e-6 |
GO:0033121 | regulation of purine nucleotide catabolic process | 6.636451e-6 |
GO:0002906 | negative regulation of mature B cell apoptosis | 6.776310e-6 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 6.793656e-6 |
GO:0042572 | retinol metabolic process | 6.859940e-6 |
GO:0030003 | cellular cation homeostasis | 6.961812e-6 |
GO:0031103 | axon regeneration | 7.015411e-6 |
GO:0060395 | SMAD protein signal transduction | 7.018727e-6 |
GO:0015850 | organic alcohol transport | 7.124288e-6 |
GO:0016337 | cell-cell adhesion | 7.293868e-6 |
GO:0019321 | pentose metabolic process | 7.741938e-6 |
GO:0051323 | metaphase | 7.932825e-6 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 7.952223e-6 |
GO:0051918 | negative regulation of fibrinolysis | 7.961815e-6 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 8.060054e-6 |
GO:0042102 | positive regulation of T cell proliferation | 8.105557e-6 |
GO:0030187 | melatonin biosynthetic process | 8.163951e-6 |
GO:0042424 | catecholamine catabolic process | 8.181541e-6 |
GO:0033559 | unsaturated fatty acid metabolic process | 8.321715e-6 |
GO:0006702 | androgen biosynthetic process | 8.444816e-6 |
GO:0019226 | transmission of nerve impulse | 9.417965e-6 |
GO:0010535 | positive regulation of activation of JAK2 kinase activity | 9.450959e-6 |
GO:0046649 | lymphocyte activation | 9.458303e-6 |
GO:0019752 | carboxylic acid metabolic process | 9.568269e-6 |
GO:0006692 | prostanoid metabolic process | 9.929627e-6 |
GO:0045056 | transcytosis | 9.967668e-6 |
GO:0016101 | diterpenoid metabolic process | 9.993287e-6 |
GO:0001666 | response to hypoxia | 1.026605e-5 |
GO:0015837 | amine transport | 1.075393e-5 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 1.104452e-5 |
GO:0032890 | regulation of organic acid transport | 1.112230e-5 |
GO:0006400 | tRNA modification | 1.153224e-5 |
GO:0060014 | granulosa cell differentiation | 1.155611e-5 |
GO:0046456 | icosanoid biosynthetic process | 1.170753e-5 |
GO:0043627 | response to estrogen stimulus | 1.179948e-5 |
GO:0016477 | cell migration | 1.181054e-5 |
GO:0010873 | positive regulation of cholesterol esterification | 1.204274e-5 |
GO:0034382 | chylomicron remnant clearance | 1.258177e-5 |
GO:0043032 | positive regulation of macrophage activation | 1.258304e-5 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 1.264294e-5 |
GO:0050902 | leukocyte adhesive activation | 1.264294e-5 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 1.289804e-5 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 1.289804e-5 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 1.289804e-5 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 1.289804e-5 |
GO:0045123 | cellular extravasation | 1.293349e-5 |
GO:0007097 | nuclear migration | 1.321003e-5 |
GO:0060290 | transdifferentiation | 1.328809e-5 |
GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | 1.332050e-5 |
GO:0050832 | defense response to fungus | 1.339779e-5 |
GO:0002831 | regulation of response to biotic stimulus | 1.345654e-5 |
GO:0051291 | protein heterooligomerization | 1.364039e-5 |
GO:0050881 | musculoskeletal movement | 1.372410e-5 |
GO:0044282 | small molecule catabolic process | 1.376287e-5 |
GO:0042035 | regulation of cytokine biosynthetic process | 1.382830e-5 |
GO:0001649 | osteoblast differentiation | 1.393796e-5 |
GO:0019344 | cysteine biosynthetic process | 1.394196e-5 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 1.432682e-5 |
GO:0051917 | regulation of fibrinolysis | 1.465505e-5 |
GO:0048535 | lymph node development | 1.488799e-5 |
GO:0006693 | prostaglandin metabolic process | 1.495282e-5 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.514524e-5 |
GO:0070932 | histone H3 deacetylation | 1.586039e-5 |
GO:0050851 | antigen receptor-mediated signaling pathway | 1.662255e-5 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 1.692421e-5 |
GO:0006082 | organic acid metabolic process | 1.693867e-5 |
GO:0043252 | sodium-independent organic anion transport | 1.699774e-5 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 1.709689e-5 |
GO:0000089 | mitotic metaphase | 1.715673e-5 |
GO:0019693 | ribose phosphate metabolic process | 1.717695e-5 |
GO:0042448 | progesterone metabolic process | 1.736202e-5 |
GO:0006349 | regulation of gene expression by genetic imprinting | 1.758872e-5 |
GO:0032964 | collagen biosynthetic process | 1.759806e-5 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 1.777122e-5 |
GO:0021623 | oculomotor nerve formation | 1.823386e-5 |
GO:0003404 | optic vesicle morphogenesis | 1.823386e-5 |
GO:0003409 | optic cup structural organization | 1.823386e-5 |
GO:0042573 | retinoic acid metabolic process | 1.828799e-5 |
GO:0002885 | positive regulation of hypersensitivity | 1.865444e-5 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006952 | defense response | 1.128060e-21 |
GO:0023052 | signaling | 1.977668e-21 |
GO:0007165 | signal transduction | 4.294930e-21 |
GO:0007154 | cell communication | 2.022038e-20 |
GO:0050896 | response to stimulus | 5.244548e-19 |
GO:0042221 | response to chemical stimulus | 3.031762e-18 |
GO:0050776 | regulation of immune response | 5.574549e-17 |
GO:0007166 | cell surface receptor linked signaling pathway | 1.733756e-16 |
GO:0050727 | regulation of inflammatory response | 2.003124e-16 |
GO:0031347 | regulation of defense response | 2.130019e-16 |
GO:0009617 | response to bacterium | 2.205709e-16 |
GO:0051716 | cellular response to stimulus | 1.666121e-15 |
GO:0032101 | regulation of response to external stimulus | 4.548319e-15 |
GO:0009607 | response to biotic stimulus | 1.517895e-14 |
GO:0006954 | inflammatory response | 4.575647e-14 |
GO:0010033 | response to organic substance | 6.150766e-14 |
GO:0009628 | response to abiotic stimulus | 7.438434e-14 |
GO:0002684 | positive regulation of immune system process | 8.094378e-14 |
GO:0032501 | multicellular organismal process | 1.134411e-13 |
GO:0032879 | regulation of localization | 1.137104e-13 |
GO:0001817 | regulation of cytokine production | 2.316241e-13 |
GO:0051707 | response to other organism | 2.587713e-13 |
GO:0051049 | regulation of transport | 3.810588e-13 |
GO:0002673 | regulation of acute inflammatory response | 4.393564e-13 |
GO:0050790 | regulation of catalytic activity | 7.385831e-13 |
GO:0048583 | regulation of response to stimulus | 8.291076e-13 |
GO:0042742 | defense response to bacterium | 9.427628e-13 |
GO:0003008 | system process | 1.098282e-12 |
GO:0050778 | positive regulation of immune response | 2.382143e-12 |
GO:0009611 | response to wounding | 4.300054e-12 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 4.692151e-12 |
GO:0065007 | biological regulation | 4.776243e-12 |
GO:0002821 | positive regulation of adaptive immune response | 7.389781e-12 |
GO:0051241 | negative regulation of multicellular organismal process | 1.375285e-11 |
GO:0043086 | negative regulation of catalytic activity | 1.497070e-11 |
GO:0002237 | response to molecule of bacterial origin | 1.602723e-11 |
GO:0002718 | regulation of cytokine production involved in immune response | 1.716747e-11 |
GO:0045765 | regulation of angiogenesis | 3.317766e-11 |
GO:0006955 | immune response | 3.413609e-11 |
GO:0006950 | response to stress | 3.474920e-11 |
GO:0019882 | antigen processing and presentation | 5.445082e-11 |
GO:0051336 | regulation of hydrolase activity | 9.838035e-11 |
GO:0032496 | response to lipopolysaccharide | 1.088081e-10 |
GO:0065008 | regulation of biological quality | 1.127193e-10 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.251041e-10 |
GO:0045833 | negative regulation of lipid metabolic process | 1.411496e-10 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.504496e-10 |
GO:0055008 | cardiac muscle tissue morphogenesis | 2.268387e-10 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 2.942186e-10 |
GO:0031349 | positive regulation of defense response | 3.906485e-10 |
GO:0048002 | antigen processing and presentation of peptide antigen | 3.969152e-10 |
GO:0002252 | immune effector process | 4.470499e-10 |
GO:0050789 | regulation of biological process | 5.388063e-10 |
GO:0032103 | positive regulation of response to external stimulus | 5.506589e-10 |
GO:0051704 | multi-organism process | 6.199741e-10 |
GO:0071219 | cellular response to molecule of bacterial origin | 6.264852e-10 |
GO:0071216 | cellular response to biotic stimulus | 7.135097e-10 |
GO:0002682 | regulation of immune system process | 7.469367e-10 |
GO:0050708 | regulation of protein secretion | 1.203222e-9 |
GO:0002697 | regulation of immune effector process | 1.332943e-9 |
GO:0002675 | positive regulation of acute inflammatory response | 1.532353e-9 |
GO:0080134 | regulation of response to stress | 1.557047e-9 |
GO:0002376 | immune system process | 1.684785e-9 |
GO:0070887 | cellular response to chemical stimulus | 1.765747e-9 |
GO:0032675 | regulation of interleukin-6 production | 1.927475e-9 |
GO:0002819 | regulation of adaptive immune response | 2.241977e-9 |
GO:0048585 | negative regulation of response to stimulus | 2.627943e-9 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 2.780244e-9 |
GO:0014070 | response to organic cyclic compound | 3.312901e-9 |
GO:0009125 | nucleoside monophosphate catabolic process | 3.471176e-9 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 5.077127e-9 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 6.259340e-9 |
GO:0051055 | negative regulation of lipid biosynthetic process | 6.476062e-9 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 6.479534e-9 |
GO:0070201 | regulation of establishment of protein localization | 6.620089e-9 |
GO:0003013 | circulatory system process | 6.933888e-9 |
GO:0035556 | intracellular signal transduction | 7.848316e-9 |
GO:0034382 | chylomicron remnant clearance | 8.730183e-9 |
GO:0002687 | positive regulation of leukocyte migration | 9.650258e-9 |
GO:0023057 | negative regulation of signaling | 1.041683e-8 |
GO:0045321 | leukocyte activation | 1.163180e-8 |
GO:0071214 | cellular response to abiotic stimulus | 1.256903e-8 |
GO:0065009 | regulation of molecular function | 1.296484e-8 |
GO:0001775 | cell activation | 1.342905e-8 |
GO:0071310 | cellular response to organic substance | 1.412588e-8 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.416065e-8 |
GO:0010574 | regulation of vascular endothelial growth factor production | 1.416065e-8 |
GO:0071222 | cellular response to lipopolysaccharide | 1.606630e-8 |
GO:0010863 | positive regulation of phospholipase C activity | 1.760393e-8 |
GO:0007586 | digestion | 1.828020e-8 |
GO:0010648 | negative regulation of cell communication | 1.954617e-8 |
GO:0048584 | positive regulation of response to stimulus | 2.054111e-8 |
GO:0006198 | cAMP catabolic process | 2.106358e-8 |
GO:0009612 | response to mechanical stimulus | 2.203167e-8 |
GO:0006810 | transport | 2.235972e-8 |
GO:0033344 | cholesterol efflux | 2.332970e-8 |
GO:0034762 | regulation of transmembrane transport | 2.561602e-8 |
GO:0050794 | regulation of cellular process | 2.590977e-8 |
GO:0060415 | muscle tissue morphogenesis | 2.704033e-8 |
GO:0051223 | regulation of protein transport | 2.953349e-8 |
GO:0051234 | establishment of localization | 3.127480e-8 |
GO:0009214 | cyclic nucleotide catabolic process | 3.768913e-8 |
GO:0046466 | membrane lipid catabolic process | 4.286959e-8 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 4.523729e-8 |
GO:0043330 | response to exogenous dsRNA | 4.915037e-8 |
GO:0008015 | blood circulation | 5.364159e-8 |
GO:0051346 | negative regulation of hydrolase activity | 5.540014e-8 |
GO:0042990 | regulation of transcription factor import into nucleus | 5.647597e-8 |
GO:0007202 | activation of phospholipase C activity | 5.917443e-8 |
GO:0032374 | regulation of cholesterol transport | 6.038037e-8 |
GO:0045088 | regulation of innate immune response | 6.447662e-8 |
GO:0044092 | negative regulation of molecular function | 6.487220e-8 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 7.119777e-8 |
GO:0050728 | negative regulation of inflammatory response | 7.539007e-8 |
GO:0032488 | Cdc42 protein signal transduction | 7.775452e-8 |
GO:0010518 | positive regulation of phospholipase activity | 7.829421e-8 |
GO:0002688 | regulation of leukocyte chemotaxis | 7.904846e-8 |
GO:0048739 | cardiac muscle fiber development | 7.960565e-8 |
GO:0050709 | negative regulation of protein secretion | 7.977038e-8 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 9.227813e-8 |
GO:0002685 | regulation of leukocyte migration | 9.577812e-8 |
GO:0050877 | neurological system process | 9.618487e-8 |
GO:0046700 | heterocycle catabolic process | 9.811070e-8 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 1.015903e-7 |
GO:0033700 | phospholipid efflux | 1.127953e-7 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 1.217247e-7 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 1.349278e-7 |
GO:0051764 | actin crosslink formation | 1.712444e-7 |
GO:0009605 | response to external stimulus | 1.730882e-7 |
GO:0002027 | regulation of heart rate | 1.761121e-7 |
GO:0046649 | lymphocyte activation | 1.791333e-7 |
GO:0048519 | negative regulation of biological process | 1.794307e-7 |
GO:0002253 | activation of immune response | 1.893998e-7 |
GO:0002699 | positive regulation of immune effector process | 1.925109e-7 |
GO:0002579 | positive regulation of antigen processing and presentation | 1.957370e-7 |
GO:0002700 | regulation of production of molecular mediator of immune response | 1.967891e-7 |
GO:0030814 | regulation of cAMP metabolic process | 2.020810e-7 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.024327e-7 |
GO:0044270 | cellular nitrogen compound catabolic process | 2.128718e-7 |
GO:0002920 | regulation of humoral immune response | 2.206002e-7 |
GO:0030817 | regulation of cAMP biosynthetic process | 2.209649e-7 |
GO:0007584 | response to nutrient | 2.346393e-7 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 2.384687e-7 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 2.392706e-7 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 2.658108e-7 |
GO:0050729 | positive regulation of inflammatory response | 2.688677e-7 |
GO:0006659 | phosphatidylserine biosynthetic process | 2.905525e-7 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 2.905525e-7 |
GO:0050707 | regulation of cytokine secretion | 2.925386e-7 |
GO:0032880 | regulation of protein localization | 3.038816e-7 |
GO:0003229 | ventricular cardiac muscle tissue development | 3.289385e-7 |
GO:0045471 | response to ethanol | 3.359488e-7 |
GO:0033275 | actin-myosin filament sliding | 4.508768e-7 |
GO:0006200 | ATP catabolic process | 4.670418e-7 |
GO:0019376 | galactolipid catabolic process | 4.685294e-7 |
GO:0048644 | muscle organ morphogenesis | 4.778047e-7 |
GO:0050830 | defense response to Gram-positive bacterium | 4.827888e-7 |
GO:0007600 | sensory perception | 5.001920e-7 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 5.206078e-7 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 5.310783e-7 |
GO:0002366 | leukocyte activation involved in immune response | 5.314603e-7 |
GO:0032755 | positive regulation of interleukin-6 production | 5.394495e-7 |
GO:0051179 | localization | 5.480882e-7 |
GO:0002250 | adaptive immune response | 5.713104e-7 |
GO:0055085 | transmembrane transport | 5.836980e-7 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 5.889611e-7 |
GO:0009991 | response to extracellular stimulus | 5.910860e-7 |
GO:0032375 | negative regulation of cholesterol transport | 5.987968e-7 |
GO:0032729 | positive regulation of interferon-gamma production | 6.011042e-7 |
GO:0046058 | cAMP metabolic process | 6.206824e-7 |
GO:0042493 | response to drug | 6.266812e-7 |
GO:0045933 | positive regulation of muscle contraction | 6.434856e-7 |
GO:0010954 | positive regulation of protein processing | 6.716791e-7 |
GO:0002540 | leukotriene production involved in inflammatory response | 6.716791e-7 |
GO:0006690 | icosanoid metabolic process | 6.977996e-7 |
GO:0010517 | regulation of phospholipase activity | 7.067603e-7 |
GO:0030100 | regulation of endocytosis | 7.549554e-7 |
GO:0030819 | positive regulation of cAMP biosynthetic process | 7.663155e-7 |
GO:0001819 | positive regulation of cytokine production | 7.750344e-7 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 8.134274e-7 |
GO:0045089 | positive regulation of innate immune response | 8.240497e-7 |
GO:0016525 | negative regulation of angiogenesis | 8.246919e-7 |
GO:0072503 | cellular divalent inorganic cation homeostasis | 8.515337e-7 |
GO:0000302 | response to reactive oxygen species | 8.905581e-7 |
GO:0006140 | regulation of nucleotide metabolic process | 9.433703e-7 |
GO:0052547 | regulation of peptidase activity | 9.461897e-7 |
GO:0034097 | response to cytokine stimulus | 9.995188e-7 |
GO:0032715 | negative regulation of interleukin-6 production | 1.067864e-6 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.082856e-6 |
GO:0009416 | response to light stimulus | 1.121573e-6 |
GO:0007522 | visceral muscle development | 1.134291e-6 |
GO:0001969 | regulation of activation of membrane attack complex | 1.189393e-6 |
GO:0009966 | regulation of signal transduction | 1.216751e-6 |
GO:0002885 | positive regulation of hypersensitivity | 1.337451e-6 |
GO:0009968 | negative regulation of signal transduction | 1.348421e-6 |
GO:0006725 | cellular aromatic compound metabolic process | 1.384833e-6 |
GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 1.430440e-6 |
GO:0006875 | cellular metal ion homeostasis | 1.439017e-6 |
GO:0044130 | negative regulation of growth of symbiont in host | 1.458915e-6 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 1.470022e-6 |
GO:0002218 | activation of innate immune response | 1.557379e-6 |
GO:0002285 | lymphocyte activation involved in immune response | 1.586608e-6 |
GO:0034764 | positive regulation of transmembrane transport | 1.586608e-6 |
GO:0006874 | cellular calcium ion homeostasis | 1.592107e-6 |
GO:0071702 | organic substance transport | 1.704606e-6 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.767181e-6 |
GO:0031667 | response to nutrient levels | 1.769422e-6 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 1.873968e-6 |
GO:0032844 | regulation of homeostatic process | 1.957089e-6 |
GO:0002696 | positive regulation of leukocyte activation | 1.997148e-6 |
GO:0060555 | induction of necroptosis by extracellular signals | 2.027229e-6 |
GO:0051591 | response to cAMP | 2.045985e-6 |
GO:0030003 | cellular cation homeostasis | 2.086436e-6 |
GO:0023051 | regulation of signaling | 2.112800e-6 |
GO:0060191 | regulation of lipase activity | 2.231946e-6 |
GO:0010243 | response to organic nitrogen | 2.244874e-6 |
GO:0010466 | negative regulation of peptidase activity | 2.472570e-6 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 2.510294e-6 |
GO:0032369 | negative regulation of lipid transport | 2.584168e-6 |
GO:0050867 | positive regulation of cell activation | 2.656922e-6 |
GO:0040008 | regulation of growth | 2.760947e-6 |
GO:0045926 | negative regulation of growth | 2.788088e-6 |
GO:0060341 | regulation of cellular localization | 2.828783e-6 |
GO:0019374 | galactolipid metabolic process | 2.878041e-6 |
GO:0002577 | regulation of antigen processing and presentation | 2.898451e-6 |
GO:0072507 | divalent inorganic cation homeostasis | 2.898466e-6 |
GO:0032368 | regulation of lipid transport | 2.988137e-6 |
GO:0046456 | icosanoid biosynthetic process | 3.135453e-6 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 3.185601e-6 |
GO:0001970 | positive regulation of activation of membrane attack complex | 3.305043e-6 |
GO:0097035 | regulation of membrane lipid distribution | 3.305043e-6 |
GO:0050710 | negative regulation of cytokine secretion | 3.344503e-6 |
GO:0009719 | response to endogenous stimulus | 3.447855e-6 |
GO:0071260 | cellular response to mechanical stimulus | 3.448008e-6 |
GO:0045087 | innate immune response | 3.492326e-6 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 3.521788e-6 |
GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 3.530026e-6 |
GO:0006658 | phosphatidylserine metabolic process | 3.761419e-6 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 3.872986e-6 |
GO:0031214 | biomineral tissue development | 3.907099e-6 |
GO:0002922 | positive regulation of humoral immune response | 3.946841e-6 |
GO:0003209 | cardiac atrium morphogenesis | 4.144235e-6 |
GO:0042304 | regulation of fatty acid biosynthetic process | 4.233019e-6 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 4.243471e-6 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 4.552079e-6 |
GO:0034655 | nucleobase-containing compound catabolic process | 4.843484e-6 |
GO:0051050 | positive regulation of transport | 4.958334e-6 |
GO:0050714 | positive regulation of protein secretion | 5.025046e-6 |
GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 5.403634e-6 |
GO:0001818 | negative regulation of cytokine production | 5.454092e-6 |
GO:0070252 | actin-mediated cell contraction | 5.537944e-6 |
GO:0001932 | regulation of protein phosphorylation | 5.544952e-6 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 5.580922e-6 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 5.674878e-6 |
GO:0015914 | phospholipid transport | 5.881841e-6 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.926308e-6 |
GO:0034380 | high-density lipoprotein particle assembly | 5.974111e-6 |
GO:0032692 | negative regulation of interleukin-1 production | 6.068695e-6 |
GO:0032642 | regulation of chemokine production | 6.095977e-6 |
GO:0010940 | positive regulation of necrotic cell death | 6.284239e-6 |
GO:0055074 | calcium ion homeostasis | 6.462256e-6 |
GO:0050995 | negative regulation of lipid catabolic process | 6.466923e-6 |
GO:0044283 | small molecule biosynthetic process | 6.687863e-6 |
GO:0051492 | regulation of stress fiber assembly | 6.765974e-6 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 6.797283e-6 |
GO:0045651 | positive regulation of macrophage differentiation | 6.865497e-6 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 6.898150e-6 |
GO:0043068 | positive regulation of programmed cell death | 7.206653e-6 |
GO:0055065 | metal ion homeostasis | 7.777107e-6 |
GO:0050870 | positive regulation of T cell activation | 7.938445e-6 |
GO:0001558 | regulation of cell growth | 8.179027e-6 |
GO:0042306 | regulation of protein import into nucleus | 8.345134e-6 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 8.462640e-6 |
GO:0007060 | male meiosis chromosome segregation | 8.515923e-6 |
GO:0071496 | cellular response to external stimulus | 8.576368e-6 |
GO:0006909 | phagocytosis | 8.617132e-6 |
GO:0043065 | positive regulation of apoptosis | 8.722803e-6 |
GO:0019932 | second-messenger-mediated signaling | 8.810236e-6 |
GO:0042325 | regulation of phosphorylation | 9.061681e-6 |
GO:0051128 | regulation of cellular component organization | 9.156630e-6 |
GO:0019220 | regulation of phosphate metabolic process | 9.548984e-6 |
GO:0010447 | response to acidity | 9.847116e-6 |
GO:0051222 | positive regulation of protein transport | 1.021181e-5 |
GO:0043462 | regulation of ATPase activity | 1.030255e-5 |
GO:0019377 | glycolipid catabolic process | 1.035281e-5 |
GO:0006941 | striated muscle contraction | 1.048899e-5 |
GO:0051251 | positive regulation of lymphocyte activation | 1.065078e-5 |
GO:0002883 | regulation of hypersensitivity | 1.083134e-5 |
GO:0060627 | regulation of vesicle-mediated transport | 1.137023e-5 |
GO:0008217 | regulation of blood pressure | 1.144103e-5 |
GO:0050766 | positive regulation of phagocytosis | 1.153607e-5 |
GO:0051046 | regulation of secretion | 1.162558e-5 |
GO:0009895 | negative regulation of catabolic process | 1.164101e-5 |
GO:0002019 | regulation of renal output by angiotensin | 1.194461e-5 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 1.261478e-5 |
GO:0055080 | cation homeostasis | 1.320865e-5 |
GO:0052548 | regulation of endopeptidase activity | 1.334310e-5 |
GO:0060193 | positive regulation of lipase activity | 1.356143e-5 |
GO:0010942 | positive regulation of cell death | 1.372321e-5 |
GO:0060907 | positive regulation of macrophage cytokine production | 1.401599e-5 |
GO:0048731 | system development | 1.438542e-5 |
GO:0042307 | positive regulation of protein import into nucleus | 1.463723e-5 |
GO:0051480 | cytosolic calcium ion homeostasis | 1.474882e-5 |
GO:0031650 | regulation of heat generation | 1.498400e-5 |
GO:0045766 | positive regulation of angiogenesis | 1.525609e-5 |
GO:0031960 | response to corticosteroid stimulus | 1.610947e-5 |
GO:0032691 | negative regulation of interleukin-1 beta production | 1.624879e-5 |
GO:0002758 | innate immune response-activating signal transduction | 1.625383e-5 |
GO:0051224 | negative regulation of protein transport | 1.645303e-5 |
GO:0007623 | circadian rhythm | 1.656475e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.718630e-5 |
GO:0071312 | cellular response to alkaloid | 1.726982e-5 |
GO:0010646 | regulation of cell communication | 1.732956e-5 |
GO:0006811 | ion transport | 1.752025e-5 |
GO:0072539 | T-helper 17 cell differentiation | 1.789783e-5 |
GO:0051606 | detection of stimulus | 1.834082e-5 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.846258e-5 |
GO:0032102 | negative regulation of response to external stimulus | 1.898551e-5 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 1.905724e-5 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 2.054532e-5 |
GO:0051345 | positive regulation of hydrolase activity | 2.094431e-5 |
GO:0010939 | regulation of necrotic cell death | 2.102255e-5 |
GO:0050921 | positive regulation of chemotaxis | 2.125144e-5 |
GO:0012502 | induction of programmed cell death | 2.146742e-5 |
GO:0046483 | heterocycle metabolic process | 2.147783e-5 |
GO:0032649 | regulation of interferon-gamma production | 2.193843e-5 |
GO:0046034 | ATP metabolic process | 2.230808e-5 |
GO:0032963 | collagen metabolic process | 2.262208e-5 |
GO:0051051 | negative regulation of transport | 2.318576e-5 |
GO:0007275 | multicellular organismal development | 2.353577e-5 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 2.408805e-5 |
GO:0002674 | negative regulation of acute inflammatory response | 2.447630e-5 |
GO:0030048 | actin filament-based movement | 2.451442e-5 |
GO:0050715 | positive regulation of cytokine secretion | 2.516489e-5 |
GO:0009308 | amine metabolic process | 2.545914e-5 |
GO:0071321 | cellular response to cGMP | 2.587606e-5 |
GO:0006917 | induction of apoptosis | 2.659567e-5 |
GO:0048523 | negative regulation of cellular process | 2.687876e-5 |
GO:0009314 | response to radiation | 2.718502e-5 |
GO:0044062 | regulation of excretion | 2.729670e-5 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 2.773969e-5 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 2.854066e-5 |
GO:0031652 | positive regulation of heat generation | 2.919960e-5 |
GO:0030449 | regulation of complement activation | 2.919960e-5 |
GO:0016311 | dephosphorylation | 3.008837e-5 |
GO:0009894 | regulation of catabolic process | 3.060942e-5 |
GO:0070665 | positive regulation of leukocyte proliferation | 3.075724e-5 |
GO:0031329 | regulation of cellular catabolic process | 3.209572e-5 |
GO:0016064 | immunoglobulin mediated immune response | 3.225902e-5 |
GO:0002449 | lymphocyte mediated immunity | 3.275151e-5 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 3.321079e-5 |
GO:0019724 | B cell mediated immunity | 3.431207e-5 |
GO:0051384 | response to glucocorticoid stimulus | 3.447989e-5 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 3.561759e-5 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 3.573423e-5 |
GO:0006470 | protein dephosphorylation | 3.618756e-5 |
GO:0042110 | T cell activation | 3.669998e-5 |
GO:0030098 | lymphocyte differentiation | 3.872666e-5 |
GO:0048513 | organ development | 3.873539e-5 |
GO:0006195 | purine nucleotide catabolic process | 4.025446e-5 |
GO:0002521 | leukocyte differentiation | 4.073400e-5 |
GO:0048518 | positive regulation of biological process | 4.099731e-5 |
GO:0006927 | transformed cell apoptosis | 4.141621e-5 |
GO:0002281 | macrophage activation involved in immune response | 4.236864e-5 |
GO:0032490 | detection of molecule of bacterial origin | 4.236864e-5 |
GO:0051341 | regulation of oxidoreductase activity | 4.241618e-5 |
GO:0051445 | regulation of meiotic cell cycle | 4.514839e-5 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 4.615337e-5 |
GO:0006163 | purine nucleotide metabolic process | 4.646642e-5 |
GO:0048016 | inositol phosphate-mediated signaling | 4.753033e-5 |
GO:0032930 | positive regulation of superoxide anion generation | 4.782572e-5 |
GO:0046942 | carboxylic acid transport | 4.895457e-5 |
GO:0032231 | regulation of actin filament bundle assembly | 5.025238e-5 |
GO:0045922 | negative regulation of fatty acid metabolic process | 5.058225e-5 |
GO:0050953 | sensory perception of light stimulus | 5.258936e-5 |
GO:0042592 | homeostatic process | 5.263654e-5 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 5.328531e-5 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 5.408630e-5 |
GO:0002706 | regulation of lymphocyte mediated immunity | 5.441922e-5 |
GO:0043901 | negative regulation of multi-organism process | 5.475332e-5 |
GO:0040020 | regulation of meiosis | 5.590262e-5 |
GO:0048878 | chemical homeostasis | 5.841030e-5 |
GO:0050865 | regulation of cell activation | 5.857860e-5 |
GO:0071827 | plasma lipoprotein particle organization | 6.032517e-5 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 6.150113e-5 |
GO:0010873 | positive regulation of cholesterol esterification | 6.169335e-5 |
GO:0072523 | purine-containing compound catabolic process | 6.177259e-5 |
GO:0032502 | developmental process | 6.183206e-5 |
GO:0003230 | cardiac atrium development | 6.264067e-5 |
GO:0044255 | cellular lipid metabolic process | 6.271284e-5 |
GO:0043434 | response to peptide hormone stimulus | 6.313929e-5 |
GO:0050711 | negative regulation of interleukin-1 secretion | 6.380563e-5 |
GO:0042488 | positive regulation of odontogenesis of dentine-containing tooth | 6.558781e-5 |
GO:0002694 | regulation of leukocyte activation | 6.617803e-5 |
GO:0031399 | regulation of protein modification process | 6.666462e-5 |
GO:0031348 | negative regulation of defense response | 6.689719e-5 |
GO:0006629 | lipid metabolic process | 6.803012e-5 |
GO:0002703 | regulation of leukocyte mediated immunity | 6.874497e-5 |
GO:0051246 | regulation of protein metabolic process | 6.924016e-5 |
GO:0010025 | wax biosynthetic process | 6.942153e-5 |
GO:0006958 | complement activation, classical pathway | 7.100745e-5 |
GO:0048535 | lymph node development | 7.214749e-5 |
GO:0010035 | response to inorganic substance | 7.607504e-5 |
GO:0046717 | acid secretion | 7.768875e-5 |
GO:0007601 | visual perception | 7.865519e-5 |
GO:0006979 | response to oxidative stress | 7.878875e-5 |
GO:0009166 | nucleotide catabolic process | 7.891474e-5 |
GO:0001890 | placenta development | 7.946951e-5 |
GO:0033574 | response to testosterone stimulus | 8.003056e-5 |
GO:0045332 | phospholipid translocation | 8.249085e-5 |
GO:0003073 | regulation of systemic arterial blood pressure | 8.342182e-5 |
GO:0043085 | positive regulation of catalytic activity | 8.381841e-5 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 8.409682e-5 |
GO:0070305 | response to cGMP | 8.480621e-5 |
GO:0015849 | organic acid transport | 8.507384e-5 |
GO:0044057 | regulation of system process | 8.514752e-5 |
GO:0009593 | detection of chemical stimulus | 8.576693e-5 |
GO:0050671 | positive regulation of lymphocyte proliferation | 8.588772e-5 |
GO:0046631 | alpha-beta T cell activation | 8.607627e-5 |
GO:0032233 | positive regulation of actin filament bundle assembly | 8.656527e-5 |
GO:0010627 | regulation of intracellular protein kinase cascade | 8.733379e-5 |
GO:0055114 | oxidation-reduction process | 8.737084e-5 |
GO:0070482 | response to oxygen levels | 8.749933e-5 |
GO:0031338 | regulation of vesicle fusion | 8.786735e-5 |
GO:0019319 | hexose biosynthetic process | 8.799359e-5 |
GO:0005976 | polysaccharide metabolic process | 8.863197e-5 |
GO:0090209 | negative regulation of triglyceride metabolic process | 8.894954e-5 |
GO:0046890 | regulation of lipid biosynthetic process | 9.182642e-5 |
GO:0030049 | muscle filament sliding | 9.488720e-5 |
GO:0006469 | negative regulation of protein kinase activity | 9.525522e-5 |
GO:0007568 | aging | 9.527887e-5 |
GO:0034284 | response to monosaccharide stimulus | 9.643568e-5 |
GO:0002221 | pattern recognition receptor signaling pathway | 9.787616e-5 |
GO:0015909 | long-chain fatty acid transport | 9.827605e-5 |
GO:0019725 | cellular homeostasis | 9.901011e-5 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 9.958124e-5 |
GO:0006869 | lipid transport | 1.010548e-4 |
GO:0007155 | cell adhesion | 1.016218e-4 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 1.033072e-4 |
GO:0000185 | activation of MAPKKK activity | 1.052074e-4 |
GO:0001702 | gastrulation with mouth forming second | 1.056734e-4 |
GO:0001101 | response to acid | 1.072408e-4 |
GO:0051348 | negative regulation of transferase activity | 1.098718e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.107538e-4 |
GO:0006691 | leukotriene metabolic process | 1.126770e-4 |
GO:0043407 | negative regulation of MAP kinase activity | 1.154088e-4 |
GO:0043154 | negative regulation of caspase activity | 1.156348e-4 |
GO:0045071 | negative regulation of viral genome replication | 1.157486e-4 |
GO:0048660 | regulation of smooth muscle cell proliferation | 1.168480e-4 |
GO:0000188 | inactivation of MAPK activity | 1.214063e-4 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 1.236952e-4 |
GO:0051353 | positive regulation of oxidoreductase activity | 1.239508e-4 |
GO:0015908 | fatty acid transport | 1.250163e-4 |
GO:0033590 | response to cobalamin | 1.250485e-4 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 1.250485e-4 |
GO:0002676 | regulation of chronic inflammatory response | 1.250837e-4 |
GO:0002757 | immune response-activating signal transduction | 1.254476e-4 |
GO:0070508 | cholesterol import | 1.269825e-4 |
GO:0032770 | positive regulation of monooxygenase activity | 1.270348e-4 |
GO:0022610 | biological adhesion | 1.312907e-4 |
GO:0007338 | single fertilization | 1.317291e-4 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 1.336406e-4 |
GO:0006022 | aminoglycan metabolic process | 1.387678e-4 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 1.394431e-4 |
GO:0003018 | vascular process in circulatory system | 1.412430e-4 |
GO:0002526 | acute inflammatory response | 1.436614e-4 |
GO:0045840 | positive regulation of mitosis | 1.458902e-4 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.472108e-4 |
GO:0048671 | negative regulation of collateral sprouting | 1.472582e-4 |
GO:0006678 | glucosylceramide metabolic process | 1.472582e-4 |
GO:0045987 | positive regulation of smooth muscle contraction | 1.524371e-4 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 1.527740e-4 |
GO:0060760 | positive regulation of response to cytokine stimulus | 1.530360e-4 |
GO:0009187 | cyclic nucleotide metabolic process | 1.542498e-4 |
GO:0010872 | regulation of cholesterol esterification | 1.548428e-4 |
GO:0070555 | response to interleukin-1 | 1.558354e-4 |
GO:0051053 | negative regulation of DNA metabolic process | 1.569875e-4 |
GO:0006812 | cation transport | 1.595185e-4 |
GO:0009268 | response to pH | 1.644421e-4 |
GO:0048525 | negative regulation of viral reproduction | 1.671793e-4 |
GO:0002443 | leukocyte mediated immunity | 1.675547e-4 |
GO:0090022 | regulation of neutrophil chemotaxis | 1.722166e-4 |
GO:0045746 | negative regulation of Notch signaling pathway | 1.722166e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 1.747512e-4 |
GO:0016055 | Wnt receptor signaling pathway | 1.769146e-4 |
GO:0048856 | anatomical structure development | 1.772201e-4 |
GO:0043279 | response to alkaloid | 1.775614e-4 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 1.819699e-4 |
GO:0045994 | positive regulation of translational initiation by iron | 1.819699e-4 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 1.819699e-4 |
GO:0002037 | negative regulation of L-glutamate transport | 1.819699e-4 |
GO:0014075 | response to amine stimulus | 1.849127e-4 |
GO:0048738 | cardiac muscle tissue development | 1.900906e-4 |
GO:0045948 | positive regulation of translational initiation | 1.930370e-4 |
GO:0002724 | regulation of T cell cytokine production | 1.976812e-4 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 1.998405e-4 |
GO:0009746 | response to hexose stimulus | 2.054946e-4 |
GO:0045851 | pH reduction | 2.075812e-4 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 2.110541e-4 |
GO:0022900 | electron transport chain | 2.126750e-4 |